C12N 2770/24144
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2770/24144 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 9 US grants and 18 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 18
- Assignees
- 9
- Inventors
- 24
- Latest grant
- 4 Jul 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 4 |
| 2020 | 1 | 3 |
| 2021 | 3 | 3 |
| 2022 | 2 | 0 |
| 2023 | 2 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 3 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions for booster vaccination against dengue4 Jul 2023US 11,690,903 B2Sanofi Pasteur Limited
- Chimeric reporter West Nile/dengue viruses and their use25 Apr 2023US 11,634,459 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Dengue vaccine unit dose and administration thereof11 Oct 2022US 11,464,815 B2Takeda Vaccines, Inc.
- Nucleic acids encoding chimeric dengue/Zika viruses optimized for growth and stability in vero cells31 May 2022US 11,344,615 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Vaccines against infectious diseases caused by positive stranded RNA viruses13 Jul 2021US 11,058,759 B2Medigen, Inc.
- Dengue vaccine unit dose and administration thereof25 Jun 2026US 2026/0174812 A1Takeda Vaccines, Inc.
- Compositions and methods of vaccination against dengue virus in children and young adults24 Jul 2025US 2025/0235522 A1Takeda Vaccines, Inc.
- Next generation mrna vaccines20 Mar 2025US 2025/0090648 A1FuTr Bio Ltda.
- Vaccines against infectious diseases caused by positive stranded rna viruses20 Feb 2025US 2025/0057932 A1Medigen, Inc.
- Compositions for Booster Vaccination Against Dengue26 Oct 2023US 2023/0338504 A1Sanofi Pasteur Limited
Most cited
By later US patents